Clinical Trials Directory

Trials / Completed

CompletedNCT00711815

A Study to Identify Markers in Blood and Tissue of HPV Clearance

Biomarkers of HPV Clearance: A Prospective Study

Status
Completed
Phase
Study type
Observational
Enrollment
197 (actual)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
Female
Age
19 Years
Healthy volunteers
Accepted

Summary

This is a research study looking at gene characteristics in blood and Pap smear samples in hopes of identifying markers that will predict if the HPV infection is present or not.

Detailed description

Because infection with high-risk human papillomavirus is a necessary cause of cervical cancer, HPV testing has many potential uses in cervical cancer screening. Unfortunately, like cytology, it suffers from a lack of specificity when used for population-based screening. Given that HPV testing detects more cases of CIN3+ than cytology and that it would probably be more practical in developing regions, finding a biomarker that would increase specificity has been the goal for much research on HPV and cervical cancer. The goal of this study is to explore potential predictors of viral clearance, specifically RNA levels of candidate genes in cervical swabs and host genetic polymorphisms, in the context of genotype-specific infection data.

Conditions

Timeline

Start date
2007-01-01
Primary completion
2010-11-01
Completion
2010-11-01
First posted
2008-07-09
Last updated
2011-08-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00711815. Inclusion in this directory is not an endorsement.